BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 117,700 shares, a decline of 21.2% from the November 15th total of 149,400 shares. Based on an average daily trading volume, of 197,300 shares, the days-to-cover ratio is presently 0.6 days.

BioStem Technologies Trading Up 5.9 %

Shares of BSEM traded up 0.97 during mid-day trading on Friday, reaching 17.21. The company’s stock had a trading volume of 60,600 shares, compared to its average volume of 38,093. The company’s fifty day moving average price is 15.25 and its two-hundred day moving average price is 11.51. The stock has a market cap of $286.05 million, a PE ratio of 25.31 and a beta of -0.62. BioStem Technologies has a 52 week low of 4.28 and a 52 week high of 28.26.

BioStem Technologies (OTCMKTS:BSEM) last released its quarterly earnings results on Tuesday, November 12th. The company reported 0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of 0.31 by 0.01. The firm had revenue of 82.56 million for the quarter, compared to the consensus estimate of 78.22 million. Research analysts anticipate that BioStem Technologies will post 1.41 EPS for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.